Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

BioFlyte Raises $5.4 Million in Series B Financing to Protect Critical Infrastructure from Airborne Biothreats

New financing will help scale manufacturing of BioFlyte’s novel biothreat surveillance solution to expand reach within aviation and mail screening applications

BioFlyte, a biothreat detection firm with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, announced that it raised $5.4M in new financing led by Scout Ventures and Cottonwood Technology Fund with additional funding from New Mexico Vintage Fund. BioFlyte will use this new funding to continue scaling its manufacturing and sales operations to meet customer demand and to develop new product configurations that will serve new markets.

AiThority Interview Insights: How to Get Started with Prompt Engineering in Generative AI Projects

“We are excited to work toward our mission of making the world a better, safer place with our investment in BioFlyte”

“This round of funding will allow us to scale our manufacturing operations and create a sales organization to drive market penetration and support our growing customer base,” said Todd Sickles, CEO, BioFlyte. “We plan to expand our market presence by providing disruptive biothreat surveillance solutions that meet the needs of business operators and emergency management personnel within enterprises that are strongly focused on protecting people and minimizing business disruption emanating from biological threats.”

BioFlyte’s flagship product is the BioTOF™ z200, a first-of-its-kind, comprehensive biothreat surveillance solution for critical infrastructure protection and mail screening. The z200 provides test results in less than five minutes and operates continuously and autonomously in critical infrastructure environments such as airports, arenas, entertainment venues, and commercial and government buildings. BioFlyte’s technology is also being used for screening within mail processing environments.

Read More about AiThority InterviewAiThority Interview with Frank Diana, Principal Futurist at Tata Consultancy Services

The system consists of a wall mount sensor capable of autonomous detection and identification of airborne toxins in real-time. It incorporates matrix-assisted laser desorption and ionization (MALDI) mass spectrometry to acquire a mass spectrum from each collected aerosol sample. The BioTOF sensor offers high sensitivity at 100 threat particles per liter of ambient air. By incorporating robust ML/AI, the instrument continuously detects, characterizes, and stores new species in its libraries for future reference, thus giving it the ability to accurately and quickly identify an unprecedented range of toxins, viruses, and bacteria such as anthrax, ricin and fentanyl.

“We are excited to work toward our mission of making the world a better, safer place with our investment in BioFlyte,” said Brad Harrison, Managing Partner of Scout Ventures, who recently joined the company’s Board of Directors. “Its revolutionary class of fieldable biothreat sampling, detection, and identification products for safety and security align squarely with Scout’s focus on dual use frontier technology. We are thrilled by the progress Todd Sickles and the entire BioFlyte team have demonstrated with their first scale deployments at Pittsburgh International Airport and at a large New York City financial institution.”

 Latest AiThority Interview Insights : AiThority Interview: Top AI and ML Trends Transforming the Customer Service Industry

 [To share your insights with us, please write to sghosh@martechseries.com] 

Comments are closed.